Dr. Guttman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St Fl 5
New York, NY 10029Phone+1 212-241-9065Fax+1 212-348-7434
Education & Training
- Tel Aviv University SacklerClass of 1998
- New York Presbyterian Hospital (Cornell Campus)Residency, Dermatology
Certifications & Licensure
- FL State Medical License 2020 - Present
- NY State Medical License 2007 - 2027
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Registry for the Atopic Dermatitis Research Network Start of enrollment: 2011 Aug 01
- Immune Reactions in Contact Dermatitis Affected Skin Start of enrollment: 2012 Jan 01
- Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsAtopic Dermatitis Yardstick update.Mark Boguniewicz, Luz Fonacier, Emma Guttman-Yassky, Peck Y Ong, Jonathan I Silverberg
Annals of Allergy, Asthma & Immunology. 2023-06-01 - 10 citationsOral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tablets.Richard B Warren, Bruce Strober, Jonathan I Silverberg, Emma Guttman, Philippe Andres
Journal of the European Academy of Dermatology and Venereology. 2023-04-01 - 12 citationsPharmacology of orismilast, a potent and selective PDE4 inhibitor.Jonathan I Silverberg, Lars E French, Richard B Warren, Bruce Strober, Kim Kjøller
Journal of the European Academy of Dermatology and Venereology. 2023-04-01
Press Mentions
- Significant Improvements: A New, Promising Long-Term Treatment for EczemaJanuary 25th, 2023
- Eczema: Experimental Drug Shows Promise in Treating Atopic DermatitisJanuary 19th, 2023
- New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term ResultsDecember 9th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: